Press "Enter" to skip to content

Posts published in “Psilocybin”

Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors

Decreased dendritic spine density in the cortex is a hallmark of several neuropsychiatric diseases, and the ability to promote cortical neuron growth has been hypothesized…

DNA Authentication and Chemical Analysis of Psilocybe Mushrooms Reveal Widespread Misdeterminations in Fungaria and Inconsistencies in Metabolites

Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examples

Microdosing psychedelics – Does it have an impact on emodiversity?

Psilocybin as a Treatment for Psychiatric Illness: A Meta-Analysis

Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activity

Hopelessness, Suicidality, and Co-Occurring Substance Use among Adolescent Hallucinogen Users-A National Survey Study

Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndrome

Structure–Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice

Lower-dose psycholytic therapy – A neglected approach

Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption

Genome sequencing progenies of magic mushrooms (Psilocybe subaeruginosa) identifies tetrapolar mating and gene duplications in the psilocybin pathway

DARK Classics in Chemical Neuroscience: Psilocybin

Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness

Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults

Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [11C]MDL 100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation

Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption

Psychedelic Drug Legislative Reform and Legalization in the US

Psilocybin in Treatment-Resistant Depression

Psilocybin as a Treatment for Psychiatric Illness: A Meta-Analysis

Pharmacokinetics and pharmacodynamics of oral psilocybin administration in healthy participants

Extensive Collection of Psychotropic Mushrooms with Determination of Their Tryptamine Alkaloids

Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial

Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin

Body mass index (BMI) does not predict responses to psilocybin

Structure–Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice

Structure–Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice

The pharmacology of psilocybin

The crystal structure of baeocystin

Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial)